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The ability of viruses to control and/or evade the host antiviral response is critical to the establishment
of a productive infection. One of the strategies utilized by West Nile virus (WNV) to circumvent the host
response is to evade detection by the pathogen recognition receptor RIG-I early in infection. To begin
elucidating the mechanisms by which WNV eludes detection, we undertook a systematic analysis of the
WNV genome and antigenome to identify RIG-I-speciﬁc pathogen associated molecular patterns
(PAMPs). Multiple segments of the WNV genome and anitigenome induced a RIG-I-speciﬁc antiviral
response. However, incorporation of the stimulatory regions into larger RNAs substantially reduced
their capacity to activate RIG-I. These results suggested that WNV evades the host response by
sequestering RIG-I-speciﬁc PAMPs within the complete genome and antigenome at early times post-
infection. Furthermore, activation of the RIG-I pathway may require the liberation of PAMPs by the
cell’s normal RNA processing pathways.
& 2012 Elsevier Inc. All rights reserved.Introduction
West Nile virus (WNV) is a positive-sense, single-stranded RNA
virus from the family Flaviviridae. The genome is 11 kb and
consists of an open reading frame (ORF) ﬂanked by 50 and 30
untranslated regions (UTRs). Within the UTRs, conserved sequences
and predicted secondary structures encode the signals for negative
strand synthesis, genome ampliﬁcation, translation, and packaging.
The incoming viral genomic RNA functions as a template for both
translation, which produces a single polyprotein, and replication.
The viral polyprotein is co- and post-translationally cleaved by host
and viral proteases to generate ten individual proteins. The struc-
tural proteins, core (C), membrane (prM/M), and envelope (E), are
involved in viral assembly, host cell binding, and entry. The seven
nonstructural (NS) proteins (NS1, NS2A/B, NS3, NS4A/B, and NS5)
support viral replication and evasion of the host antiviral response.
Following polyprotein synthesis, genomic RNA is transcribed by the
viral polymerase, NS5, to generate the complementary minus-strand
antigenome, which serves as a template for synthesis of additional
genomic RNA. Newly synthesized genomic RNA is either translatedll rights reserved.
en).by the host cell or packaged into virus particles (Brinton, 2001,
2002; Chambers et al., 1990; Lindenbach et al., 2007).
In areas where WNV is endemic, such as the Middle East,
Africa, and Asia, infection is typically asymptomatic or associated
with a mild febrile illness known as West Nile fever (Petersen and
Roehrig, 2001). In contrast, recent outbreaks in the Western
hemisphere have been marked by an increase in disease severity,
including meningitis, encephalitis, and acute ﬂaccid paralysis
(Hayes and Gubler, 2006; Nash et al., 2001; Klee et al., 2004).
Since its introduction into the United States in 1999, WNV has
spread to every state within the continental United States, as well
as parts of Canada, Mexico and the Caribbean (information found
on the CDC website www.cdc.gov/ncidod/dvbid/westnile/index.
htm). As of January 2012, yearly outbreaks of WNV have resulted
in 13,229 reported cases with neurological complications and
1,263 deaths, making WNV the leading cause of mosquito-borne
neuroinvasive disease in the United States.
The ability to rapidly sense an invading pathogen and respond
appropriately is a critical factor inﬂuencing the outcome of
infection. The intracellular pathogen recognition receptor (PRR)
RIG-I plays a critical role in sensing a wide variety of viruses,
including positive strand viruses such as WNV, Japanese encepha-
litis virus (JEV), hepatitis C virus (HCV), dengue virus and poliovirus,
and negative strand RNA viruses such as paramyxoviruses, inﬂu-
enza, and vesicular stomatitis virus (VSV) (Fredericksen et al., 2008;
J.G. Shipley et al. / Virology 432 (2012) 232–238 233Loo et al., 2008; Saito et al., 2008; Kato et al., 2006; Rehwinkel et al.,
2010). The fact that RIG-I detects a wide variety of viruses spanning
multiple families suggests that it is able to interact with multiple
substrates. Recent evidence indicates that double stranded struc-
tures within viral RNAs function as primary activators of RIG-I
during infection (Baum et al., 2010; Berg et al., 2012; Kato et al.,
2008; Malathi et al., 2010), though 50 triphosphate (50ppp) moieties
enhance detection of short dsRNAs (Hornung et al., 2006; Pichlmair
et al., 2006; Schlee et al., 2009; Schmidt et al., 2009). Additionally,
poly-U/UC motifs in the genomes of HCV, measles, rabies and Ebola
viruses are important for activating RIG-I (Saito et al., 2008). Once
activated by a viral PAMP, RIG-I initiates a signaling cascade that
results in the activation of latent transcription factors such as
interferon regulatory factor 3 (IRF-3) (Hiscott, 2007; Stetson and
Medzhitov, 2006; Takahasi et al., 2008). Activation of IRF-3 leads to
the induction of type-I interferons (IFN) as well as a subset of
antiviral effector proteins such as IFN-stimulated gene 56 (ISG56),
(Hiscott, 2007; Kawai et al., 2005; Stetson and Medzhitov, 2006;
Takahasi et al., 2008). The induction of these IRF-3 target genes
results in the establishment of an antiviral state within in the cell,
which blocks viral replication.
As eukaryotes evolved strategies to combat invading pathogens,
viruses have co-evolved processes to escape them. While many
viruses actively impede the RIG-I signaling pathway (Pachler and
Vlasak, 2011; Gack et al., 2009; Masatani et al., 2010; Ling et al.,
2009; Papon et al., 2009; Barral et al., 2009; Bowie and Unterholzner,
2008), the pathogenic strain of WNV, WNV New York (WNV-NY),
eludes detection at early times post-infection (Fredericksen and Gale,
2006). However, the mechanism(s) by which WNV evades detection
early during infection is currently unclear. We have previously
demonstrated that cells treated with UV-inactivated WNV fail to
induce an antiviral response, suggesting that RIG-I senses a product
of viral replication (Fredericksen and Gale, 2006). Furthermore, the
WNV-NY genome lacks a poly-U/UC region, suggesting that RIG-I
senses either dsRNA structures within the WNV genome or anti-
genome or an as of yet unidentiﬁed stimulatory motif. To distinguish
between these possibilities, we undertook a systematic analysis of
the WNV-NY genome and antigenome to deﬁne RIG-I-speciﬁc
PAMPs. Multiple RIG-I stimulatory regions were identiﬁed through-
out the WNV genome and antigenome. However, incorporation ofMo
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Fig. 1. The 50 UTR (þ) and 30 UTR () region of the WNV-NY genome induce an antivira
16 h prior to infection with SenV or transfection with 500 ng of the indicated RNAs in tr
activity. Values represent the average luciferase expression compared to mock (7stan
was performed using Dunnett’s multiple comparison analysis, *po0.05, **po0.01 **
genomic or antigenomic 50 and 30 UTRs. (B) Cells were transfected with 50UTRþCS-eGthese regions into larger RNAs abolished their stimulatory potential,
suggesting that theWNV PAMPs are masked in the context of the full
genome and antigenome. This masking of the PAMPs likely accounts
for WNV’s ability to evade the innate immune response early during
infection.Results
The 50 and 30 UTRs of WNV induce an antiviral response
Because secondary structures within RNA are essential for
recognition by and activation of RIG-I (Baum et al., 2010; Berg
et al., 2012; Kato et al., 2008; Lu et al., 2010; Malathi et al., 2010;
Myong et al., 2009; Rehwinkel et al., 2010; Schlee et al., 2009;
Schmidt et al., 2009), we hypothesized that the highly structured 50
and 30 UTRs of WNV stimulate RIG-I. Therefore, we assessed the
capacity of these regions to stimulate a RIG-I-dependent antiviral
response using a luciferase reporter assay. Huh7 cells were trans-
fected with a RIG-I-dependent luciferase reporter, ISG56-luc
(Grandvaux et al., 2002), and subsequently either infected with
Sendai Virus (SenV), a potent RIG-I-speciﬁc activator of the innate
immune response, or transfected with RNAs corresponding to the
genomic (þ) or antigenomic () 50 and 30 UTRs. Cell lysates were
recovered and analyzed for luciferase expression 8 h after RNA
transfection to ensure that the induction of luciferase expression
was due to the primary activation of the RIG-I signal transduction
pathway and not subsequent feedback ampliﬁcation loops. Signiﬁ-
cant induction of luciferase expression was detected in SenV-
infected cells as well as cultures transfected with the WNV 50 (þ)
and 30 () UTRs (Fig. 1A). In contrast, neither the WNV 30 UTR (þ)
nor WNV 50 UTR () fragments induced luciferase expression. In
order to more accurately mimic the RNAs present during a native
infection, the stimulatory capacity of the 50 UTR (þ) containing a
cap structure and the 50 UTR () containing a 50 PPP were also
examined (Fig. 1A). Neither the presence of a capped structure on
the 50 UTR (þ) nor a 50 PPP on the 50 UTR () altered the
stimulatory capacity of these fragments.
The robust induction of the antiviral response by the capped 50
UTR (þ) fragment suggested that the incoming viral genome isMo
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Fig. 2. Multiple regions of the WNV genome and antigenome induce an antiviral response. Cells were transfected with ISG56-luc and pCMV-Renilla as described in Fig. 1.
Cultures were subsequently transfected with 500 ng of RNA fragments corresponding to genomic (A) or antigenomic (B) orientation of WNV genes. Luciferase expression
was assessed as described in Fig. 1.
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Fig. 3. WNV PAMPs induce a RIG-I-speciﬁc antiviral response. (A) Puriﬁed RIG-I
was incubated with control dsRNA or the indicated WNV RNA fragments prior to
the addition of trypsin. Digestion products were separated on a 12.5% SDS
polyacrylamide gel and visualized by Coomassie stain. (B) Huh7.5 monolayers
were transfected with luciferase reporter constructs and 500 ng of the indicated
RNAs or pEF-ﬂagN-RIG, as described in Fig. 1. Luciferase expression was assessed
as described in Fig. 1.
J.G. Shipley et al. / Virology 432 (2012) 232–238234capable of functioning as a PAMP for RIG-I detection. However,
the failure of WNV to initiate a rapid antiviral response indicates
that this region is not accessible to RIG-I early in infection
(Fredericksen and Gale, 2006). Interactions between the 50 and
30 ends of the WNV genome have been shown to be essential for
genome replication, suggesting that the 50 UTR does not function
as an independent structural element during infection (Brinton
and Dispoto, 1988; Hahn et al., 1987; Khromykh et al., 2001;
Zhang et al., 2008). Therefore, we generated a construct consisting
of the 50 UTR to the conserved sequences (CS) element, located in
the N-terminal coding region of the C gene, linked to the 30 UTR
by the egfp reporter gene (50UTRþCS-eGFP-30UTR). Neither CIP-
treated nor capped 50UTRþCS-eGFP-30UTR RNAs stimulated luci-
ferase expression (Fig. 1B), suggesting that the 50 UTR is not a
functional PAMP when presented to the cell in this context.
Multiple regions of the WNV genome and antigenome induce the host
antiviral response
To determine whether other regions of the genome also harbor
RIG-I PAMPs, the stimulatory capacity of RNAs corresponding
to the individual WNV genes was assessed. While several frag-
ments induced low to moderate levels of luciferase expression,
only RNAs corresponding to NS2a (þ), E (), NS2a () and
NS4a () functioned as potent stimulators of the antiviral
response (Fig. 2A and B). Thus, multiple regions within the
WNV genome and antigenome are capable of stimulating an
antiviral response.
The antiviral response to WNV PAMPs is RIG-I-dependent
The rapid and robust induction of luciferase expression by the
50 UTR (þ), 30 UTR (), NS2a (þ), E (), NS2a () and NS4a ()
RNAs was indicative of a RIG-I-dependent response. To conﬁrm
the speciﬁcity of this response, the ability of the identiﬁed PAMPs
to form a stable complex with RIG-I was examined using limited
trypsin digestion. This assay assesses the ability of a PAMP to
induce conformational changes in RIG-I associated with the
generation of the signaling-active form (Saito et al., 2007, 2008;
Takahasi et al., 2008). Incubation of Escherichia coli-puriﬁed RIG-I
with each of the WNV PAMPs identiﬁed above resulted in the
accumulation of a 17-kDa trypsin resistant band indicative of the
signaling-active from of RIG-I (Fig. 3A). However, only a weak
band was detected in the presence of the 50 UTR (þ) fragment,
suggesting that, unlike the other PAMPS, this fragment does not
bind tightly to RIG-I. We further veriﬁed the speciﬁcity of theidentiﬁed PAMPs using the RIG-I-deﬁcient Huh7.5 cell line
(Fig. 3B) (Blight et al., 2002; Sumpter et al., 2005). High levels of
luciferase expression were detected in control cells transfected
with a constitutively active form of RIG-I, N-RIG. In contrast, WNV
RNA fragments did not induce an antiviral response in the
absence of functional RIG-I. Together, these ﬁndings indicated
that the WNV PAMPs identiﬁed above induce a RIG-I-dependent
antiviral response.
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J.G. Shipley et al. / Virology 432 (2012) 232–238 235Incorporation of WNV-NY PAMPs into larger RNAs masks their
stimulatory capacity
To determine whether WNV RNA sequences or structures
spanning the individual genes are capable of stimulating RIG-I,
we also tested the stimulatory capacity of overlapping segments
of the viral genome and antigenome (Fig. 4A and B). With the
exception of the 50 UTR-prM (þ) fragment, the overlapping
segments failed to induce high levels of luciferase expression,
despite the fact that several segments contained the highly
stimulatory NS2a (þ), E (), NS2a () or NS4a () regions
(Fig. 4A and B). In this experiment, we transfected cells with
equivalent amounts of each of the RNAs based on mass. To ensure
that the lack of stimulation by the larger fragments was not due
to differences in the RNA copy number introduced into the cell,
we also assessed the stimulatory capacity of these regions by
transfecting equivalent moles of the various fragments. While
similar levels of induction were detected for the NS2a (þ), E (),
NS2a () and NS4a () regions under these conditions, equal
molar amounts of the larger RNA fragments did not induce
luciferase expression (Fig. 4C). This suggests that RIG-I is unable
to efﬁciently detect WNV PAMPs in the context of a larger RNA
even when equivalent RNA copy numbers are introduced into
the cell.
WNV genomic and subgenomic RNAs do not induce RIG-I activation
The lack of RIG-I activation by the 50UTRþCS-eGFP-30UTR
RNAs and the larger overlapping segments of the viral genome
suggested that the stimulatory capacity of these PAMPs is masked
in the context of full-length viral RNAs. Therefore, we assessed
the stimulatory capacity of full-length genomic RNA isolated from
culture supernatants (FL-WNV) or produced through in vitro
transcription and capping (capped-FL-IT-WNV) (Fig. 5A). Both
forms of genomic RNA failed to induce luciferase expression,
further supporting the hypothesis that WNV PAMPs are masked
in the context of the full genome.
Together our ﬁndings suggested that processing of the viral
genome and antigenome is necessary to expose the identiﬁed RIG-I
PAMPs. During infection, incomplete digestion of genomic viral
RNA by the 50–30 exoribonuclease XRN1 results in the accumula-
tion of a highly structured 30 UTR-derived monophosphorylated
subgenomic RNA (sfRNA) (Brinton et al., 1986; Funk et al., 2011;
Pijlman et al., 2008). To determine if sfRNA is a PAMP, we tested
the stimulatory capacity of both a CIP-treated and a monopho-
sphorylated sfRNA construct. Although luciferase expression in
cells transfected with either CIP-treated or monophosphorylated
sfRNA was consistently higher than background levels, the increase
in luciferase expression did not reach statistical signiﬁcance for
either RNA (Fig. 5B). This ﬁnding suggests that sfRNA does not
function as a major PAMP during WNV infection and is consistent
with previous reports that the sfRNA promotes WNV pathogenesis
(Pijlman et al., 2008; Schuessler et al., 2012).Mo
c
Se
n
NS
2A
 (+ E (
NS
2A
 (
NS
4A
 (
E-
NS
2B
 (+
NS
2B
-N
S4
B (
+
NS
2B
-E
 (
NS
4B
-N
S2
B (
Fig. 4. Larger RNAs containing WNV PAMPs fail to activate an antiviral response.
Huh7 monolayers were transfected with ISG56-luc and pCMV-Renilla as described
in Fig. 1 and subsequently transfected with 500 ng of RNA fragments correspond-
ing to the indicated sections of the WNV genome (A) or antigenome (B) or with
equal molar amounts (2 pmol) of the indicated RNAs (C). Luciferase expression
was assessed as described in Fig. 1.Discussion
In this study we utilized a systematic approach to identify RIG-I-
dependent PAMPs present in the WNV genome and antigenome. Our
ﬁndings demonstrated that WNV, in contrast to many other viruses
(Kato et al., 2006; Plumet et al., 2007; Saito et al., 2008; Wang et al.,
2008), encodes multiple segments located throughout the genome
and antigenome that are capable of stimulating RIG-I. The lack of
sequence similarity between the stimulatory regions suggests that
RIG-I detects dsRNA structures within these regions rather than a
speciﬁc sequence motif. Secondary structural predictions indicatethat the identiﬁed stimulatory regions within the WNV genome are
highly structured (Supplemental Figs. S1–5). While these structural
predictions need to be conﬁrmed experimentally, they provide a
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Fig. 5. WNV genomic and subgenomic RNAs do not induce an antiviral response. Cells were transfected with ISG56-luc and pCMV-Renilla as described in Fig. 1. Cultures
were subsequently transfected with 500 ng of: (A) genomic RNA isolated from culture supernatants (FL-WNV) or full length in vitro transcribed and capped WNV genomic
RNA (capped-FL-IT-WNV) or (B) the indicated sfRNA constructs. Luciferase expression was assessed as described in Fig. 1 the indicated sfRNA constructs. Luciferase
expression was assessed as described in Fig. 1.
J.G. Shipley et al. / Virology 432 (2012) 232–238236conceptual scaffold to begin deﬁning the structural elements involved
in RIG-I detection. Our ﬁndings also suggest that the intact WNV
genome and antigenome are poor activators of RIG-I. Larger RNA
fragments as well as the full-length genomic RNA failed to induce the
rapid activation of the antiviral response. These ﬁndings are consis-
tent with a recent report demonstrating that RIG-I does not bind to
the full-length genome of SenV (Baum et al., 2010).
Multiple factors may play a role in masking WNV PAMPs
within full-length viral RNAs. It is possible that the secondary
structures detected by RIG-I are altered or abolished in the
context of the full genome. Alternatively, tertiary structures
within the viral RNA may sterically hinder RIG-I’s ability to bind
the PAMPs. Comparison of the secondary structure predictions for
the 50UTR alone and the 50UTR in the context of the 50UTR-prM
fragment suggests that the structure of this region is not sub-
stantially altered when incorporated into larger RNAs
(Supplemental Fig. S6). However, in the case of the incoming
genome, the stimulatory capacity of the capped 50 UTR (þ) may
be obstructed by several additional factors. Upon entering cells,
the viral genome undergoes cap-dependent translation to gen-
erate the viral polyprotein. Thus, host translation machinery may
block RIG-I’s access to this region. The viral genomic RNA also
serves as a template for synthesis of the negative sense anti-
genome, which requires interactions between the conserved
sequence (CS) elements located within the 50 end of core and
the 30 UTR as well as base pairing between a 50 UAR (upstream
initiation AUG region element) and a 30 UAR (Brinton and Dispoto,
1988; Zhang et al., 2008; Hahn et al., 1987; Khromykh et al.,
2001). Therefore, long distance interactions between the 50 and 30
UTRs may sequester the stimulatory signals within the 50 UTR
early in infection. The observation that the 50UTR-prM fragment
stimulated RIG-I, while the 50UTRþCS-eGFP-30UTR fragment did
not, is consistent with this hypothesis.
Our ﬁndings also suggested that WNV evades detection at early
times post-infection by sequestering potential PAMPS within the
viral genome and antigenome. The mechanism(s) by which WNV
PAMPs eventually become accessible to RIG-I during the course of
infection are currently under investigation. As previously demon-
strated for SenV and inﬂuenza virus (Baum et al., 2010), subgenomic
defective interfering (DI) particles may play a role in stimulating
RIG-I activation. The deletion of large segments from the viral
genome may result in the exposure of WNV PAMPs that were
previously buried within the full-length viral RNAs, thus providing
the proper context for RIG-I recognition. In addition, the normalcellular processes of RNA degradation may be involved in the
exposing of WNV PAMPs within the genome during the course of
infection. This hypothesis is supported by the observation that large
fragments of the WNV genome, which fail to induce the rapid
activation of RIG-I, induce an antiviral response approximately 30 h
post-transfection (Fredericksen, unpublished results). The fact that
the subgenomic sfRNA of WNV failed to substantially activate RIG-I
suggested that the exonuclease XRN1 is not involved in liberating
RIG-I PAMPs. However, other cellular pathways, such as the ‘‘no-go’’
RNA degradation pathway, which is triggered by stalled ribosomal
movement, may be involved in the processing of WNV viral RNAs
(Doma and Parker, 2006; Tomecki and Dziembowski, 2010).
Furthermore, as has been demonstrated for HCV, activation of the
OAS/RNAseL pathway later in infection may liberate additional
PAMPs that help sustain and/or amplify the antiviral response
(Malathi et al., 2010; Scherbik et al., 2006). In the case of the
WNV antigenome, alternative RNA processing pathways may be
required for the release of virally encoded PAMPs. The antigenome
of WNV exists within the cell in two forms, the double-stranded
replicative form (ds-RF) and the replicative intermediate (RI). The
ds-RF consists of a nascent antigenome paired with the genome
template, while the RI consists of a single copy of the viral
antigenome and multiple strands of nascent genomic RNA being
synthesized (Gillespie et al., 2010; Westaway et al., 1999). Detection
of viral antigenome by the host cell may be limited due to the fact
that the RI is sequestrated within membrane invagination. However,
processing the ds-RF by either the cell’s RNAi or ADAR/TSN pathway
may liberate PAMPs from the WNV antigenome (Scadden, 2005;
Umbach and Cullen, 2009). These mechanisms, as well as other as of
yet unknown cellular degradation pathways, may contribute, indi-
vidually or in concert, to the liberation of PAMPs. Further analysis of
the WNV RNAs produced both in vitro and in vivo will be necessary
to more precisely map the WNV stimulatory regions within the viral
genome and antigenome and to elucidate how PAMPs are produced
over the course of infection.Materials and methods
Cells and viruses
Huh7 and Huh7.5 (Apath) cells were propagated in Dulbelco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% FBS,
2 mM L-glutamine, 1 mM sodium pyruvate, 1 mM non-essential
Table 1
Position in the WNV-NY genome of RNA used in experiments. The nucleotide
positions are based on the sequence from GenBank accession no. AF404756.
Name Location in genome
50UTR 1–97
Core (C) 98–465
Pre-membrane (prM) 406–966
Envelope (E) 904–2469
Non-structural 1 (NS1) 2407–3525
Non-structural 2a (NS2a) 3526–4218
Non-structural 2b (NS2b) 4219–4611
Non-structural 3 (NS3) 4612–6468
Non-structural 4a (NS4a) 6469–6915
Non-structural 4b (NS4b) 6916–7680
Non-structural 5 (NS5) 7681–10395
30UTR 10396–11029
50UTR to conserved sequence (50UTRþCS) 1–196
50UTR-prM 1–966
C-E 98–2467
E-NS2b 979–4102
NS2b-NS4b 4231–7679
NS4b-NS5 6916–10389
NS5-30UTR 7681–11029
50UTRþCs-eGFP-30UTR 1–196, 10396–11029
J.G. Shipley et al. / Virology 432 (2012) 232–238 237amino acids and antibiotic/antimycotic solution (complete DMEM).
Sendai virus (SenV), Cantell strain was obtained from Charles River.
Plasmids
pFLWNV (Shi et al., 2002) was used as a template for PCR-
ampliﬁcation of the indicated segments of the WNV-NY genome
(Table 1). Primer sequences are available upon request. Ampliﬁed
segments were cloned into pVL-blunt (a gift from Dr. Vincent Lee),
pBluKSM or pWSK29 (a gift from Dr. Sydney Kushner, Wang and
Kushner, 1991) and the sequence conﬁrmed. The reporter plasmids
pISG56-luc ( a gift from Dr. Ganes Sens, Grandvaux et al., 2002) and
pCMV-Renilla (Promega) encode the ﬁreﬂy luciferase gene under
transcriptional control of the ISG56 promoter and the Renilla lucifer-
ase gene under the constitutively active cytomegalovirus (CMV) early
promoter, respectively. pEF-ﬂag-N-RIG encodes the constitutively
active N-terminus of RIG-I (Yoneyama et al., 2004).
RNA fragments
In vitro transcribed RNA fragments were generated according
to the manufacturer’s protocol (Ampliscribe T3 and T7 kits;
Epicentre). Brieﬂy, a 20 ml reaction mixture containing 1 mg of
linearized plasmid encoding the indicated RNAs was incubated at
42 1C for 2 h. DNA template was subsequently removed from the
reaction by treating with DNase I. RNA was recovered by phenol/
chloroform extraction followed by ethanol precipitation. Unless
otherwise indicated, RNAs were treated with calf alkaline phos-
phatase (CIP) to remove free 50 triphosphates (New England
Biolabs). The purity of the RNAs was conﬁrmed by polyacrylamide
gel electrophoresis. The NS2b fragment was further puriﬁed on a
6% polyacrilamide gel containing 8 M urea. The RNA was eluted
overnight at 4 1C from the excised gel fragments in buffer
containing 200 mM NaCl, 10 mM Tris–HCl pH 7.5, 1 mM EDTA.
The eluted RNA was precipitated with ethanol, aliquoted and
stored at 80 1C. The Amplicap kit (Epicentre) was used to
generate the capped 50 UTR segment and full length genomic
RNA. Monophosphorylated sub-genomic WNV RNA (sfRNA) was
generated by incubating CIP-treated in vitro transcribed sfRNA
with T4 polynucleotide kinase according to the manufacturer’s
instructions (NEB). WNV genomic RNA was isolated from culture
supernatants recovered from WNV-NY infected cells. Cell debriswas removed by low speed centrifugation at 1500 rpm for 5 min
and genomic RNA was recovered by Trizol (Invitrogen) extraction.
Luciferase reporter assays
Subconﬂuent monolayers of Huh7 or Huh7.5 cells in a 48 well
plate were transfected with 100 ng of ISG56-luc and 20 ng of pCMV-
Renilla using Lipofectamine 2000 transfection reagent (Invitrogen).
Where indicated, cells were also transfected with 200 ng of pEF-
ﬂagN-RIG. At 16 h post-transfection, cells were mock-transfected,
transfected with 500 ng or 2 pmol of the indicated RNAs using
TransMessenger transfection reagent (Qiagen), or infected with SenV
(100 HA units), in triplicate. Cell lysates were prepared 8 h after RNA
transfection or infection with SenV and luciferase levels were
detected using a dual luciferase kit according to the manufacturer’s
protocol (Promega). Luciferase activity was quantiﬁed using a Bert-
hold Centro XS3 LB960 luminometer. Normalized luciferase levels
were determined by dividing ﬁreﬂy luciferase levels by control Renilla
luciferase levels. Values represent the average luciferase expression
compared to mock (7standard error) from a minimum of two
independent experiments. Statistical analysis was performed using
Dunnett’s multiple comparison analysis.
Trypsin digestion
Control dsRNA (Invivogen) or the indicated WNV RNA frag-
ments (30 pmol) were incubated with puriﬁed E. coli-produced
RIG-I (15 pmol) for 15 min at room temperature. The RNA/RIG-I
mixtures were digested with trypsin (0.83 mg) for 15 min at 37 1C.
Trypsin was inactivated by the addition of protease inhibitor
(Sigma) and the digestion products were separated on a 12.5%
SDS polyacrylamide gel. Bands were visualized using Imperial
Protein Stain (Thermo scientiﬁc).Acknowledgments
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